Faron to Host Bexmarilimab Update Webcast
Faron Pharmaceuticals Oy (“Faron” or “Company”) Faron to Host Bexmarilimab Development Update Webcast on September 20, 2022 Press Release, September 14, 2022 at 9:00 am EEST / 7:00 am BST / 2:00 am EDT TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces that the Company will host a webcast to provide an update on the development of